What Investors Should Know About Juno Therapeutics Recent Trial Stop and Restart
The only thing more surprising than Juno Therapeutics surprising halt to its JCAR015 trial might be how quickly the FDA approved the trial starting again.
This podcast was recorded on Jul. 20, 2016.